Jennifer K Raymond1, Cari L Berget1, Kimberly A Driscoll1, Kaitlin Ketchum1, Cynthia Cain1, John F Fred Thomas2,3,4. 1. 1 Barbara Davis Center for Childhood Diabetes, University of Colorado Anschutz Medical Campus , Aurora, Colorado. 2. 2 Department of Telehealth, Children's Hospital Colorado , Aurora, Colorado. 3. 3 Department of Psychiatry, University of Colorado School of Medicine , Aurora, Colorado. 4. 4 Department of Epidemiology, University of Colorado School of Public Health , Aurora, Colorado.
Abstract
BACKGROUND: Young adults with type 1 diabetes (T1D) face many challenges in managing their diabetes, resulting in suboptimal glycemic control and often loss to follow-up. Comprehensive strategies are needed to engage this population in diabetes care and improve outcomes. This pilot study investigated the feasibility and acceptability of the Colorado Young Adults with Type 1 Diabetes (CoYoT1) Clinic-an innovative clinical care model for young adults with T1D, incorporating telemedicine and peer interactions. SUBJECTS AND METHODS: Forty-five patients with T1D, 18-25 years of age, participated in this study. Patients completed one routine, diabetes clinic appointment, using Health Insurance Portability and Accountability-approved, Web-based videoconferencing from a location of their choosing. The clinic visit consisted of an individual appointment with a diabetes provider and a group appointment with other young adults, facilitated by a certified diabetes educator. Patients completed a satisfaction survey and reported the time lost from school or work to complete the virtual appointment compared with time typically lost to complete a traditional, in-person, visit. RESULTS: Patients reported high levels of satisfaction with the virtual clinic and high levels of perceived support from the peer interaction. Additionally, patients reported saving over 6 h from their work or school day when completing their diabetes clinic visit virtually instead of in-person. CONCLUSIONS: In this cross-sectional pilot study, the CoYoT1 Clinic, incorporating Web-based videoconferencing and peer interactions, was feasible and acceptable for young adults with T1D. This model may potentially increase engagement with diabetes care in the young adult population. However, further research is needed to fully evaluate the intervention.
BACKGROUND: Young adults with type 1 diabetes (T1D) face many challenges in managing their diabetes, resulting in suboptimal glycemic control and often loss to follow-up. Comprehensive strategies are needed to engage this population in diabetes care and improve outcomes. This pilot study investigated the feasibility and acceptability of the Colorado Young Adults with Type 1 Diabetes (CoYoT1) Clinic-an innovative clinical care model for young adults with T1D, incorporating telemedicine and peer interactions. SUBJECTS AND METHODS: Forty-five patients with T1D, 18-25 years of age, participated in this study. Patients completed one routine, diabetes clinic appointment, using Health Insurance Portability and Accountability-approved, Web-based videoconferencing from a location of their choosing. The clinic visit consisted of an individual appointment with a diabetes provider and a group appointment with other young adults, facilitated by a certified diabetes educator. Patients completed a satisfaction survey and reported the time lost from school or work to complete the virtual appointment compared with time typically lost to complete a traditional, in-person, visit. RESULTS:Patients reported high levels of satisfaction with the virtual clinic and high levels of perceived support from the peer interaction. Additionally, patients reported saving over 6 h from their work or school day when completing their diabetes clinic visit virtually instead of in-person. CONCLUSIONS: In this cross-sectional pilot study, the CoYoT1 Clinic, incorporating Web-based videoconferencing and peer interactions, was feasible and acceptable for young adults with T1D. This model may potentially increase engagement with diabetes care in the young adult population. However, further research is needed to fully evaluate the intervention.
Authors: Katharine C Garvey; Howard A Wolpert; Lori M Laffel; Erinn T Rhodes; Joseph I Wolfsdorf; Jonathan A Finkelstein Journal: Endocr Pract Date: 2013 Nov-Dec Impact factor: 3.443
Authors: Kellee M Miller; Nicole C Foster; Roy W Beck; Richard M Bergenstal; Stephanie N DuBose; Linda A DiMeglio; David M Maahs; William V Tamborlane Journal: Diabetes Care Date: 2015-06 Impact factor: 19.112
Authors: Colleen L Wood; Scott A Clements; Kim McFann; Robert Slover; John F Thomas; R Paul Wadwa Journal: Diabetes Technol Ther Date: 2015-08-21 Impact factor: 6.118
Authors: Kathryn S Bryden; David B Dunger; Richard A Mayou; Robert C Peveler; H Andrew W Neil Journal: Diabetes Care Date: 2003-04 Impact factor: 19.112
Authors: Katharine C Garvey; Margaret G Beste; Donna Luff; Astrid Atakov-Castillo; Howard A Wolpert; Marilyn D Ritholz Journal: Adolesc Health Med Ther Date: 2014-10-20
Authors: Agnieszka Butwicka; Louise Frisén; Catarina Almqvist; Björn Zethelius; Paul Lichtenstein Journal: Diabetes Care Date: 2015-02-03 Impact factor: 19.112
Authors: Janice Wiley; Mary Westbrook; Janet Long; Jerry R Greenfield; Richard O Day; Jeffrey Braithwaite Journal: Diabetes Ther Date: 2014-02-12 Impact factor: 2.945
Authors: Wen Wan; Aviva G Nathan; M Reza Skandari; Parmida Zarei; Mark W Reid; Jennifer K Raymond; Elbert S Huang Journal: Diabetes Care Date: 2019-06-12 Impact factor: 19.112
Authors: Elizabeth A Pyatak; Kristine Carandang; Cheryl L P Vigen; Jeanine Blanchard; Jesus Diaz; Alyssa Concha-Chavez; Paola A Sequeira; Jamie R Wood; Robin Whittemore; Donna Spruijt-Metz; Anne L Peters Journal: Diabetes Care Date: 2018-01-19 Impact factor: 19.112
Authors: Matthew F Bouchonville; Margaret M Paul; John Billings; Jessica B Kirk; Sanjeev Arora Journal: Curr Diab Rep Date: 2016-10 Impact factor: 4.810